APA

Martins F., Catarino C., Rocha-Pereira P., Reis F., Sameiro-Faria M., Miranda V., Belo L., Bronze-da-Rocha E., Costa E. & Santos-Silva A. (20140822). Haptoglobin 2-2 phenotype is associated with decreased serum iron levels in endstage renal disease patients resistant to rhEPO therapy. : British journal of biomedical science.

Chicago

Martins F, Catarino C, Rocha-Pereira P, Reis F, Sameiro-Faria M, Miranda V, Belo L, Bronze-da-Rocha E, Costa E and Santos-Silva A. 20140822. Haptoglobin 2-2 phenotype is associated with decreased serum iron levels in endstage renal disease patients resistant to rhEPO therapy. : British journal of biomedical science.

Harvard

Martins F., Catarino C., Rocha-Pereira P., Reis F., Sameiro-Faria M., Miranda V., Belo L., Bronze-da-Rocha E., Costa E. and Santos-Silva A. (20140822). Haptoglobin 2-2 phenotype is associated with decreased serum iron levels in endstage renal disease patients resistant to rhEPO therapy. : British journal of biomedical science.

MLA

Martins F, Catarino C, Rocha-Pereira P, Reis F, Sameiro-Faria M, Miranda V, Belo L, Bronze-da-Rocha E, Costa E and Santos-Silva A. Haptoglobin 2-2 phenotype is associated with decreased serum iron levels in endstage renal disease patients resistant to rhEPO therapy. : British journal of biomedical science. 20140822.